Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644130
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere UniversityNot Yet RecruitingNot Applicable
NCT07644130Not Yet Recruiting
Not Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University
NCT07645768
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alternative to Conventional Posterior Double Plating in Extra-Articular Distal Shaft Humeral FracturesCairo UniversityActive Not RecruitingNot Applicable
NCT07645768Active Not Recruiting
Not Applicable
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alter...Cairo University
NCT07645066
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node DysfunctionShanghai Tong Ren HospitalNot Yet RecruitingNot Applicable
NCT07645066Not Yet Recruiting
Not Applicable
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients...Shanghai Tong Ren Hospita...
NCT07646379
Effects of Spinal Mobilization With Leg Movement With and Without Neural Flossing Technique in Lumbar RadiculopathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646379Not Yet Recruiting
Not Applicable
Effects of Spinal Mobilization With Leg Movement With and Without Neural Flossin...Riphah International Univ...
NCT07646509
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom DisorderUniversity of ViennaRecruitingNot Applicable
NCT07646509Recruiting
Not Applicable
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic...University of Vienna
NCT07643831
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2- Early or Locally Advanced/Metastatic Breast CancerGenentech, Inc.Unknown
NCT07643831Unknown
—
Expanded Access Program to Provide Giredestrant to Participants With ER+, HER2-...Genentech, Inc.
NCT07645300
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical CenterNot Yet RecruitingPhase 2
NCT07645300Not Yet Recruiting
Phase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Med...
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
NCT07645612
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra MalaysiaNot Yet RecruitingNot Applicable
NCT07645612Not Yet Recruiting
Not Applicable
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra Malaysia
NCT07646054
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.Not Yet RecruitingNot Applicable
NCT07646054Not Yet Recruiting
Not Applicable
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.
NCT07645027
Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patient With Cervical Spinal Cord InjuriesRiphah International UniversityRecruitingNot Applicable
NCT07645027Recruiting
Not Applicable
Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patie...Riphah International Univ...
NCT07644442
Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male SubjectsHutchmedCompletedPhase 1
NCT07644442Completed
Phase 1
Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male SubjectsHutchmed
NCT07646002
Effectiveness of Balloon Blowing and Deep Breathing Exercise on Increasing Peripheral Oxygen Saturation in Patients With Chronic Obstructive Pulmonary DiseaseIndonesia UniversityCompletedNot Applicable
NCT07646002Completed
Not Applicable
Effectiveness of Balloon Blowing and Deep Breathing Exercise on Increasing Perip...Indonesia University
NCT07644767
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty LtdNot Yet RecruitingPhase 2
NCT07644767Not Yet Recruiting
Phase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Lt...
NCT07646028
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLCNot Yet RecruitingPhase 1
NCT07646028Not Yet Recruiting
Phase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07644013
Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaPeking University First HospitalRecruiting
NCT07644013Recruiting
—
Prospective Multicenter Registry Study of Multiple System Atrophy in ChinaPeking University First H...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07646132
Focal Extracorporeal Shock Wave Therapy With Two Different Dosing Regimens for Chronic Low Back PainArmando Tonatiuh Avila GarciaNot Yet RecruitingNot Applicable
NCT07646132Not Yet Recruiting
Not Applicable
Focal Extracorporeal Shock Wave Therapy With Two Different Dosing Regimens for C...Armando Tonatiuh Avila Ga...
NCT07644169
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG) in Healthy Adults Following PG ExposureAmerican Beverage AssociationNot Yet RecruitingNot Applicable
NCT07644169Not Yet Recruiting
Not Applicable
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG)...American Beverage Associa...
NCT07646223
Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisFimlab laboratoriesNot Yet RecruitingPhase 2
NCT07646223Not Yet Recruiting
Phase 2
Vancomycin Efficacy in Response to Dysbiosis in Atypical ColitisFimlab laboratories
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed2 (10%)
Active, not recruiting1 (5%)
Unknown1 (5%)
not_applicable11 (55%)
Phase 24 (20%)
Phase 13 (15%)
Not Specified2 (10%)